{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:26:44Z","timestamp":1791041204231,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["26713002"],"award-info":[{"award-number":["26713002"]}]},{"name":"JSPS KAKENHI","award":["26560231"],"award-info":[{"award-number":["26560231"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jconrel.2015.08.026","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T10:00:06Z","timestamp":1439546406000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"special_numbering":"C","title":["Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma"],"prefix":"10.1016","volume":"216","author":[{"given":"Takashi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Miyabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.08.026_bb0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PPO.0b013e3181eacbd8","article-title":"Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy","volume":"16","author":"Gajewski","year":"2010","journal-title":"Cancer J."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1479-5876-9-204","article-title":"A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma","volume":"9","author":"Hamid","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0015","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0020","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0025","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS\u2013cGAMP\u2013STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/325279a0","article-title":"Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid","volume":"325","author":"Ross","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0045","doi-asserted-by":"crossref","first-page":"18933","DOI":"10.1016\/S0021-9258(17)30606-3","article-title":"The cyclic diguanylic acid regulatory system of cellulose synthesis in Acetobacter xylinum. Chemical synthesis and biological activity of cyclic nucleotide dimer, trimer, and phosphothioate derivatives","volume":"265","author":"Ross","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0050","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.178.4.2171","article-title":"Bacterial c-di-GMP is an immunostimulatory molecule","volume":"178","author":"Karaolis","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0060","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/ni.2460","article-title":"The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response","volume":"13","author":"Parvatiyar","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.04.004","article-title":"A new adjuvant delivery system \u2018cyclic di-GMP\/YSK05 liposome\u2019 for cancer immunotherapy","volume":"184","author":"Miyabe","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2012.09.009","article-title":"A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo","volume":"163","author":"Sato","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0075","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijpharm.2012.11.006","article-title":"Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex","volume":"441","author":"Nakamura","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0080","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00262-004-0540-x","article-title":"Escape from immunotherapy: possible mechanisms that influence tumor regression\/progression","volume":"53","author":"Ahmad","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000328505","article-title":"NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor\u2013ligand interactions","volume":"3","author":"Morgado","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(09)70400-0","article-title":"Immunity unleashed in melanoma","volume":"11","author":"Erdmann","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2013.07.004","article-title":"The nanoparticulation by octaarginine-modified liposome improves alpha-galactosylceramide-mediated antitumor therapy via systemic administration","volume":"171","author":"Nakamura","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0100","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/JVI.00037-14","article-title":"Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-kappaB activation through TBK1","volume":"88","author":"Abe","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/scbi.2001.0398","article-title":"Tumor cell recognition by natural killer cells","volume":"12","author":"Long","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.2007.00563.x","article-title":"The trafficking of natural killer cells","volume":"220","author":"Gregoire","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.127.1.34","article-title":"In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice","volume":"127","author":"Habu","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0120","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1084\/jem.20091573","article-title":"Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation","volume":"207","author":"Ebihara","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20010938","article-title":"Reciprocal activating interaction between natural killer cells and dendritic cells","volume":"195","author":"Gerosa","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0605978104","article-title":"Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells","volume":"104","author":"Akazawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0135","doi-asserted-by":"crossref","first-page":"e04177","DOI":"10.7554\/eLife.04177","article-title":"Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses","volume":"3","author":"Chiba","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbamem.2005.02.001","article-title":"Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression","volume":"1669","author":"Ambegia","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0145","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1073\/pnas.050588297","article-title":"In vivo natural killer cell activities revealed by natural killer cell-deficient mice","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0150","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-230X(05)93006-6","article-title":"Classical and nonclassical HLA class I antigen and NK cell-activating ligand changes in malignant cells: current challenges and future directions","volume":"93","author":"Chang","year":"2005","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.08.026_bb0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20050994","article-title":"NKG2D function protects the host from tumor initiation","volume":"202","author":"Smyth","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2015.08.026_bb0175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915300717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915300717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T05:07:09Z","timestamp":1691903229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915300717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":35,"alternative-id":["S0168365915300717"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.026","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}